Ongoing Development. The Parties acknowledge and agree that additional Development will be required to obtain Regulatory Approvals for Products. After the Effective Date, as between the Parties, except as set forth in the Initial Development Plan (as the same may be amended in accordance with Section 3.1.2)
Ongoing Development. Throughout the Term of this Agreement, we may (at our sole discretion) perform additional development works or modifications to the EarlyWorks Services.
Ongoing Development. The Parties acknowledge and agree that additional Development will be required to obtain Regulatory Approvals for the Licensed Products in the Territory. After the effective date of the Exclusive License Agreement, Receptos shall be solely responsible for Development of the Licensed Products in the Territory.
Ongoing Development. The Parties acknowledge and agree that additional Development will be required to obtain Regulatory Approvals for the Licensed Products in the Territory. After the Effective Date, Xynomic shall be solely responsible for, and has full decisional power with respect to, Development of the Licensed Products in the Territory, subject to Pharmacyclics’ obligation to wind up and close all clinical trials which were sponsored by Pharmacyclics prior to the Effective Date.
Ongoing Development. 8.1 As identified at the outset, the Council and its Community Planning Partners in East Ayrshire agreed to have a joint SOA in place from 1 April 2008.
Ongoing Development. The Parties acknowledge and agree that additional Development will be required to obtain Regulatory Approvals for the Licensed Compounds or Licensed Products in the Territory. After the Effective Date, Licensee shall be solely responsible, in its sole discretion, for Development of the Licensed Compounds and the Licensed Products in the Territory.
Ongoing Development. Wasabi may develop and provide ongoing innovation to the Wasabi Service, including new features, functionality, and efficiencies. In the event Wasabi adds new features or functionality (collectively, “New Features”) to the Wasabi Service, Wasabi may offer the New Features to you at no additional charge or, if Wasabi generally charges customers for such functionality, Wasabi may condition your use of the New Features on the payment of additional Fees.
Ongoing Development. BTE’s strategic plan involves creating a competitive advantage in the industry through the continual improvement of the performance, availability, scalability and reliability of the Products. Accordingly, Vendor and BTE shall, by means of product evaluation and the iterative development process more particularly described below, fully cooperate with each other to: (a) monitor [**] – Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange Commission. and assess the availability and reliability of the Products in order to achieve reliability and availability standards set forth in this Agreement, it being agreed that the parties shall develop and regularly update reliability and availability standards (“Reliability/Availability Standards”) applicable to the Products following commercial release of such Products; (b) monitor and assess other performance criteria of the Products as referenced in the Documentation; and (c) to transfer know-how as reasonably requested by BTE for Product use and maintenance.
Ongoing Development. The Parties acknowledge and agree that additional Development will be required to obtain Regulatory Approvals for the Licensed Products in the Territory. Forest shall have the sole and exclusive right, at its sole cost and expense, to Develop (or have Developed) the Licensed Products in the Territory, consistent with the Development Plan, where applicable, and under the oversight of the JDC. Xxxxxxx shall not, directly or indirectly, whether alone or together with a Third Party, Develop any Licensed Product for any purpose in the Territory other than to support commercialization of a Returned Licensed Product in any Terminated Territory. For the avoidance of doubt, (a) Forest may Develop (or have Developed) the Licensed Products in the Territory outside of the Development Plan in countries that are not addressed in the Development Plan, and (b) Xxxxxxx shall bear, and shall not be entitled to reimbursement for, any costs and expenses incurred by Xxxxxxx prior to the Effective Date or, except as otherwise expressly provided in this Agreement, any costs or expenses incurred by Xxxxxxx in performing its obligations under this Agreement.
Ongoing Development. As of the Effective Date, GPC Biotech is conducting a Phase III Clinical Study for the Initial Indication described more fully in the Development Plan (the “SPARC Study”) and certain Phase I, Phase I/II and Phase II Clinical Studies for the Licensed Product in the Territory as listed in the Development Plan. The Parties acknowledge and agree that the SPARC Study is a pivotal study which is intended to be sufficient for the filing of an MAA for the Initial Indication in the European Union.
